Cullinan Therapeutics has announced a licensing agreement with Genrix Bio for global rights to velinotamig, a clinical-stage ...

This program supports undergraduate, graduate, and medical students conducting lupus-focused research under the guidance of experienced mentors.

In a new study, researchers identified eight disease activity domains for further development into the new Treatment Response Measure for Systemic Lupus Erythematosus (TRM-SLE), a clinical trial ...

In this episode of the Lupus Foundation of America's The Expert Series podcast, we explore the intersection of menopause and lupus, highlighting the unique challenges faced by women with lupus during ...

Clinical trials aid people with lupus, caregivers and researchers in furthering science of lupus treatments and medications. In this episode of The Expert Series, we sit down and talk with Stephanie ...

The following transcript is automatically generated and may contain typos or misspellings. Please listen to the episode for the most accurate language. Host 0:06 Welcome to The Expert Series, brought ...

The Lupus Foundation of America is profoundly concerned by the reorganization and significant staff reductions taking place at the U.S. Department of Health and Human Services (HHS) in addition to ...

Mesenchymal stem cells (MSCs) are unique adult stem cells with immunosuppressive properties that also may play a key role in preventing autoimmunity. In a new study, researchers identified metabolic ...

Members of the Systemic Lupus Erythematosus International Collaborating Clinics (SLICC) group along with experienced physicians providing lupus clinical care and research in Africa convened to ...

Today, the U.S. Food and Drug Administration (FDA) has accepted Genentech’s Supplemental Biologics License Application (sBLA) for Gazyva® (Obinutuzumab), for the potential treatment of lupus nephritis ...

Interested in getting research like this straight to your inbox? Subscribe to our bimonthly Inside Lupus Research email for all the latest. A charitable organization with 501(c)(3) tax-exempt status.